The Lancet21d
Low-dose aspirin versus placebo in postpartum venous thromboembolism: a multi-national, pilot, randomised, placebo-controlled trial
aDivision of Hematology and Hematological Malignancies, Department of Medicine, University of Calgary, Calgary, AB, Canada bDepartment of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine ...
Frontiers27d
Efficacy and safety of anticoagulants on venous thromboembolism: a systematic review and network meta-analysis of randomized controlled trials
The present study intends to comprehensively compare the efficacy and safety of various anticoagulants in VTE. Methods: Medline, Embase, and Cochrane Library from their inception up to August 2023 ...
Medscape2y
Development and Implementation of a Program to Assess Medical Patients' Need for Venous Thromboembolism Prophylaxis
Purpose: The development and implementation of a program to assess medical patients' need for venous thromboembolism (VTE) prophylaxis are described. Summary: The pharmacy services, medicine, and ...
Medscape11y
Improving Hospital Venous Thromboembolism Prophylaxis With Electronic Decision Support
Background: Venous thromboembolism (VTE) disease prophylaxis rates among medical inpatients have been noted to be <50%. Objective: Our objective was to evaluate the effectiveness and safety of a ...
ahajournals.org16y
The Epidemiology of Venous Thromboembolism in the Community
Among patients hospitalized for acute medical illness, active cancer is a major venous thromboembolism risk factor. After controlling for cancer, additional independent risk factors for venous ...